http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102044530-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-912 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102044530-B1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION FOR TREATING RETINAL DISEASES COMPRISING Nkx3.2 AND FRAGMENT THEREOF |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating retinal disease, including Nkx3.2 and fragments thereof as an active ingredient. Nkx3.2 and / or fragments thereof according to the present invention inhibit retinal degeneration due to oxidative stress and preserve visual function. In addition, the Nkx3.2 and / or fragments thereof inhibit cell death by oxidative stress of retinal pigment epithelial cells and inhibit choroidal neovascularization and retinal edema. Therefore, the composition comprising the Nkx3.2 and / or fragments thereof as an active ingredient can be usefully used for the prevention or treatment of retinal diseases or macular degeneration. |
| priorityDate | 2017-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 324.